732 related articles for article (PubMed ID: 34107695)
1. Analysis of the physiological and pathological factors of hospitalized patients taking warfarin and the correlation between drug interactions and warfarin efficacy.
Zhang L; Chen W; Gan D
Ann Palliat Med; 2021 May; 10(5):5400-5406. PubMed ID: 34107695
[TBL] [Abstract][Full Text] [Related]
2. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
3. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
[TBL] [Abstract][Full Text] [Related]
4. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
5. The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery.
Collinge CA; Kelly KC; Little B; Weaver T; Schuster RD
J Orthop Trauma; 2012 Oct; 26(10):568-73. PubMed ID: 22441640
[TBL] [Abstract][Full Text] [Related]
6. Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions.
Zhang K; Young C; Berger J
J Manag Care Pharm; 2006 Oct; 12(8):640-8. PubMed ID: 17269842
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function.
Hirai T; Hamada Y; Geka Y; Kuwana S; Hirai K; Ishibashi M; Fukaya Y; Kimura T
Eur J Clin Pharmacol; 2017 Nov; 73(11):1491-1497. PubMed ID: 28795244
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
[TBL] [Abstract][Full Text] [Related]
9. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
Abadi U; Ellis MH
Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611
[TBL] [Abstract][Full Text] [Related]
10. Predisposing preventable factors in patients with bleeding due to warfarin usage: Evaluation of 114 patients.
Beyan E; Beyan C; Vaizoğlu SA
Clin Appl Thromb Hemost; 2010 Dec; 16(6):684-7. PubMed ID: 19520686
[TBL] [Abstract][Full Text] [Related]
11. The Magnitude of the Warfarin-Amiodarone Drug-Drug Interaction Varies With Renal Function: A Propensity-Matched Cohort Study.
Miano TA; Yang W; Shashaty MGS; Zuppa A; Brown JR; Hennessy S
Clin Pharmacol Ther; 2020 Jun; 107(6):1446-1456. PubMed ID: 32112562
[TBL] [Abstract][Full Text] [Related]
12. Prediction Model for Significant Bleeding in Patients with Supratherapeutic International Normalized Ratio After Oral Administration of Warfarin.
Pourafkari L; Baghbani-Oskouei A; Savadi-Oskouei S; Ghaffari S; Parizad R; Tajlil A; Nader ND
Clin Drug Investig; 2019 Jun; 39(6):533-542. PubMed ID: 30887419
[TBL] [Abstract][Full Text] [Related]
13. Ocular bleeding related to warfarin anticoagulation in patients with mechanical heart valve and atrial fibrillation.
Biyik I; Mercan I; Ergene O; Oto O
J Int Med Res; 2007; 35(1):143-9. PubMed ID: 17408066
[TBL] [Abstract][Full Text] [Related]
14. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.
Zakai NA; Walker RF; MacLehose RF; Adam TJ; Alonso A; Lutsey PL
J Thromb Haemost; 2018 Dec; 16(12):2403-2412. PubMed ID: 30240508
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
16. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
17. Life-threatening retroperitoneal bleeding due to warfarin-drug interactions.
Chan TY
Pharmacoepidemiol Drug Saf; 2009 May; 18(5):420-2. PubMed ID: 19283775
[TBL] [Abstract][Full Text] [Related]
18. Major bleeding risk associated with warfarin and co-medications in the elderly population.
Vitry AI; Roughead EE; Ramsay EN; Preiss AK; Ryan P; Gilbert AL; Caughey GE; Shakib S; Esterman A; Zhang Y; McDermott RA
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1057-63. PubMed ID: 22039594
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
Perona S; Ford M; Rindone J
J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
[TBL] [Abstract][Full Text] [Related]
20. A study of anticoagulant therapy in patients with coronary artery disease.
Puspitasari AD; Salean DDC; Hasmono D; Hartono R; Ardiana M
J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):473-478. PubMed ID: 34214300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
